Literature DB >> 6782033

The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase.

J A Jedziniak, L T Chylack, H M Cheng, M K Gillis, A A Kalustian, W H Tung.   

Abstract

The sorbitol pathway in human lenses is evaluated on the enzymic level. Adult lenses, normal and nondiabetic as well as diabetic cataracts, are found to contain limited levels of aldose reductase (AR) and high levels of polyol dehydrogenase (PD) relative to the animal lens. AR is confined primarily to the lens epithelium and is two to three times higher in juvenile lenses than in the adult lens. The level of AR in the epithelium of juvenile lenses is sufficient to cause significant osmotic stress. The Km of glucose of AR is roughly 200 mM, whereas the Km for NADPH is 0.06 mM. NADP inhibits human lens AR noncompetitively and has a Ki equivalent to the Km for NADPH. PD occurs in both the lens epithelium and cortex, remains persistently high with age, and decreases with increased cortical involvement. The Km of sorbitol for PD is 1.4 mM and for NAD is 0.06 mM. NADH (Ki 0.002 mM) competitively inhibits PD in the forward direction. PD purified 100-fold from diabetic and nondiabetic cataracts and normal lenses exhibit similar kinetic constants. PD has an extremely high Vmax in the fructose-to-sorbitol direction. The Km of fructose is 40 mM and for NADH is 0.02 mM. At high enough concentration, alrestatin also inhibits PD. The added activities of AR and PD in producing sorbitol and fructose in combination with decreased hexokinase with age may account for diabetic cataract formation in human lenses exposed to a high glucose stress. Nucleotide levels are reported for senile cataractous lenses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6782033

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

1.  Galactitol is not a cause of senile cataract.

Authors:  H Arola; P Sillanaukee; E Aine; T Koivula; M Isokoski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 2.  Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.

Authors:  Alejandro Gugliucci
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

3.  Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis.

Authors:  R P Eaton; C Qualls; J Bicknell; W L Sibbitt; M K King; R H Griffey
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 4.  Vitamin C and the Lens: New Insights into Delaying the Onset of Cataract.

Authors:  Julie C Lim; Mariana Caballero Arredondo; Andrea J Braakhuis; Paul J Donaldson
Journal:  Nutrients       Date:  2020-10-14       Impact factor: 5.717

5.  Refractive change in hyperglycaemia: hyperopia, not myopia.

Authors:  P R Eva; P T Pascoe; D G Vaughan
Journal:  Br J Ophthalmol       Date:  1982-08       Impact factor: 4.638

6.  Bovine lens aldehyde reductase (aldose reductase). Purification, kinetics and mechanism.

Authors:  A B Halder; M J Crabbe
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

7.  Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.

Authors:  Nicholas C Holoman; Jacob J Aiello; Timothy D Trobenter; Matthew J Tarchick; Michael R Kozlowski; Emily R Makowski; Darryl C De Vivo; Charandeep Singh; Jonathan E Sears; Ivy S Samuels
Journal:  J Neurosci       Date:  2021-02-23       Impact factor: 6.167

8.  Human erythrocyte sorbitol metabolism and the role of sorbitol dehydrogenase.

Authors:  Y Nagasaka; S Fujii; T Kaneko
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

9.  Polyol-pathway enzymes of human brain. Partial purification and properties of sorbitol dehydrogenase.

Authors:  M M O'Brien; P J Schofield; M R Edwards
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

10.  Transient hyperopia with lens swelling at initial therapy in diabetes.

Authors:  Y Saito; G Ohmi; S Kinoshita; Y Nakamura; K Ogawa; S Harino; M Okada
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.